The latest study conducted by Nautilus is the first to undertake a comprehensive examination of the tau proteoform landscape at a large scale. This analysis unveiled distinct disease-related alterations, presenting a novel pool of possible biomarkers and targets for drug development. Nautilus plans to expand this method to various disease fields, highlighting its potential impact.